#ThinkSabio US Market Morning Brief
Pre-Market Gainers:
$TELO +39% Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
$PRHI +36%
$SPRB +15% Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)
Pre-Market Decliners:
$SOPA – 20% Society Pass Shares Explode After Analyst Upgrade
$AEHR -16%Aehr Test Systems (AEHR) Q1 2026 Earnings Call Highlight:Revenue: $11 million, a decrease from $13.1 million in the same period last year
Pre-Market Penny Gainers:
$PCSA +21% Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
$BENF +11%
$RVSN +10%
Headlines:
$LLY Lilly’s Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis
$AMD CITIGROUP RAISES ADVANCED MICRO DEVICES TARGET PRICE TO $215 FROM $180
$RKLB Rocket Lab will launch its “Owl New World” mission Oct 14 for Japan’s Synspective